Low-Grade Systemic Inflammation Profile, Unrelated to
Homocysteinemia, in Obese Children by V. Economou, Emanuel et al.
© 2005 Hindawi Publishing Corporation
Mediators of Inﬂammation • 2005:6 (2005) 337–342 • PII: S0962935105509104 • DOI: 10.1155/MI.2005.337
RESEARCH COMMUNICATION
Low-Grade Systemic Inﬂammation Proﬁle, Unrelated
to Homocysteinemia, in Obese Children
Emanuel V. Economou,1 Ariadne V. Malamitsi-Puchner,2 Christos P. Pitsavos,3
Evangelia E. Kouskouni,1 Ioanna Magaziotou-Elefsinioti,4 and George Creatsas5
1Hormone Laboratory, 2nd Clinic for Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, 11528 Athens, Greece
2Division of Neonatology, 2nd Clinic for Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, 11528 Athens, Greece
3Department of Cardiology, Hippokration Hospital, University of Athens, 11527 Athens, Greece
4Department of Pediatrics, Tzaneion Hospital, 18536 Pireaus, Greece
52nd Clinic for Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, 11528 Athens, Greece
Received 1 August 2005; accepted 5 September 2005
To investigate in prepubertal obese children (POC) the proﬁle of chronic low-grade systemic inﬂammation (CLGSI) and its relation
to homocysteinemia, 72 POC were evaluated for serum C-reactive protein (CRP) and amyloid A (SAA) levels, both markers of
CLGSI, and plasma levels of total homocysteine (tHcy), an independent risk factor for adult atherosclerosis, in comparison to 42
prepubertal lean children (PLC). The main observations in POC were higher CRP levels compared to PLC, positive association of
SAA levels to CRP levels, no association of CRP or SAA levels to tHcy levels. Thus, in POC, positively interrelated to each other,
elevated CRP and unaltered SAA levels reveal a unique proﬁle of the CLGSI, not explaining homocysteinemia-induced risk for
future atherosclerosis.
INTRODUCTION
Several cardiovascular risk factors are present in obese
children,amongwhicharechroniclow-gradesystemicin-
ﬂammation and homocysteinemia [1].
Obesity is now widely accepted as a promoter of a
chronic low-grade inﬂammatory reaction favoring the
development of atherosclerosis and cardiovascular dis-
ease [2], in both children and adolescents [3, 4]w h o
are free of other pathological conditions. Chronic low-
grade systemic inﬂammation, usually a persistent but
more sublte than acute phase inﬂammatory response, can
be measured by circulating C-reactive protein (CRP) and
serum amyloid A (SAA) which may also have direct pro-
inﬂammatory actions [5, 6]. They both are nonspeciﬁc
acute phase reactants, primarly synthesized in liver and
at least equally sensitive to reﬂect chronic low-grade sys-
temic vascular inﬂammation [7]. Moreover, highly sensi-
tive newer assays for CRP and SAA can now detect pre-
viously unnoticed chronic low-grade systemic inﬂamma-
tion [8, 9]. In obese subjects, hepatic biosynthesis and
maintenance of circulating CRP and SAA is up-regulated
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by adipocytokines, such as interleukins 1 and 6, tumor
necrosis factor A, and, for some authors, leptin, all se-
creted by adipose tissue [10]. However, although equally
sensitive and similarly up-regulated, CRP and SAA are
diﬀerentially determined in circulation. Circulating CRP
levels are determined by both environmental factors and
a moderate but signiﬁcant degree of heritability while cir-
culating SAA levels are determined exclusively by envi-
ronmental factors [11, 12]. Moreover, several studies de-
scribe diﬀerential, population-speciﬁc, local or systemic
response of CRP and SAA to chronic low-grade vascular
inﬂammation [5, 13, 14, 15]. These variations could indi-
cate the existence of positive and negative control mech-
anisms that permit, independently, the induction of CRP
or SAA levels to fulﬁll the host-speciﬁc low-grade inﬂam-
matory response and it is likely to be of relevance to the
causation of future disease.
Mild to moderate elevation of circulating total homo-
cysteine (tHcy), commonly referred to as homocysteine-
mia, is generally considered to be an independent risk
factor for atherosclerosis [16]. The strength of the asso-
ciation between an elevated tHcy and cardiovascular dis-
ease seems to vary among populations [17]. In adults,
considerable evidence has been accumulated to support
that the link between tHcy and atherothrombosis can-
not be explained by associations of tHcy with the chronic
low-grade inﬂammation estimated from serum CRP [13].
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we recently demonstrated that, independently of age and
sex, a modest elevation of plasma tHcy is, at least, indi-
rectly associated with childhood obesity [8, 20]. However
the molecular pathogenesis underlying all these observa-
t i o n si nv i v oh a sy e tt ob ef u l l yd e ﬁ n e d .
Prepubertal obese children (POC) represent a unique
study population in that limitation of confounding by
inﬂammation-related diseases and subclinical cardiovas-
cular disease is expected. To our knowledge no data ex-
ist in prepubertal childhood obesity exploring the proﬁle
of chronic low-grade inﬂammation with regard not only
to circulating CRP but also to circulating SAA and more-
over,investigatingapossiblerelationshipamongtHcyand
circulating markers of this speciﬁc type of chronic low-
grade systemic inﬂammation. The present study intended
to investigate in POC the proﬁle of chronic low-grade sys-
temic inﬂammation as estimated by acute phase reactants
CRP and SAA, their possible interrelation, and moreover,
a possible association among CRP, SAA, and tHcy. This
would help to determine whether there is some under-
lying process related to this speciﬁc type of inﬂamma-
tion that might be relevant to homocysteine-mediated fu-
ture atherosclerosis in POC. The ﬁndings of this study
suggest that a diﬀerential proﬁle of chronic low-grade
systemic inﬂammation, in that, although interrelated to
each other, only CRP levels which are negatively related
to high-density lipoprotein (HDL) cholesterol, not SAA
levels which are unrelated to HDL cholesterol, are ele-
vated, is observed in prepubertal childhood obesity and
this is unlikely to be the link between prepubertal child-
hood obesity-associated homocysteinemiaandadulthood
atherosclerosis.
MATERIALS AND METHODS
Participants
The study, approved by the Ethics Committee of our
General Hospital, involved 72 consecutive prepubertal
obese children (POC) and lasted from January to Octo-
ber 2002. As prepubertal children (24 females, 18 males)
were deﬁned those aged 9–10 years. Criterion for obe-
sity was body mass index (BMI) greater than 95th per-
centile of the National Growth Charts, and individuals at-
tending the pediatric and adolescent outpatient clinic of
the above-mentioned General Hospital for a basic obe-
sity check-up and fulﬁlling the above criterion were in-
cluded in the study as the POC group. BMI was calcu-
lated as weight in kilograms divided by height in square
meters (kg/m2). Parents were asked to present their chil-
dren after an overnight fast. None of the children was
on any weight management program. At admission, a
medicalhistoryandphysicalexaminationwereperformed
to ensure that the participants were healthy. All prepu-
bertal children were nonsmokers and had normal blood
cell counts, serum iron levels, and liver and renal func-
tions as assessed by standard clinical chemistry analyses.
No participants were taking multivitamin preparations or
medications known to aﬀect lipid metabolism. No dislip-
idaemia was manifested in relevant electrophoresis. Phys-
ical activity of all participants was limited to light gym-
nastics for 45 minutes, twice a week at school, according
to the National School Program. Resting blood pressure
was measured in the sitting position after a 15-minute
rest using a mercury sphygmomanometer and a cuﬀ ap-
propriately sized for the arm of the subject. Forty-two
healthy prepubertal children (21 females, 21 males), on
no medications, with BMI less than the 75th percentile
on the National Growth Charts, deﬁned as lean (PLC),
served as controls. Controls were also nonsmokers and
physical activity was also limited to school gymnastics.
Controls underwent the same laboratory tests—as exam-
ined subjects—and those tests were normal. Characteris-
tic data of all participants appear on Table 1.I n f o r m e d
consent was obtained from each child and legal guardian.
AnalyticalMethods
After an overnight fast, venous blood samples were
taken between 7:30 and 9:30 AM. Serum concentra-
tions of CRP were measured by means of high-sensiti-
vity-enhanced immunonephelometry using the Behring
Nephelometer System (Behring Diagnostics GmbH, Mar-
burg, Germany). The intra- and interassay coeﬃcients of
variation of CRP were <4.4% and <5.7%, respectively,
and the analytical sensitivity was 0.18mg/L. SAA con-
centrations were measured, in dublicate, by ELISA kit
(BioSource International, Camarillo, Calif). The intra-
andinterassaycoeﬃcientsofvariationofSAAwere<7.7%
and <10.8%, respectively, and the analytical sensitivity
was 5 ng/mL. Concentrations of plasma tHcy (homo-
cysteine, disulphide homocysteine, and mixed disulphide
homocysteine-cysteine,allintheirfreeandproteinbound
forms) were assessed in frozen (−70◦C) EDTA plasma
on Abbott IMx analyzer using ﬂuorescence polarization
immunoassay technology. The intra- and interassay co-
eﬃcients of variation of tHcy were 1.6% and 4.9%, re-
spectively, and the analytical sensitivity was 0.16µmol/L
(Abbott Diagnostics, Wiesbaden-Delkenheim, Germany).
Cholesterol, triglycerides, and HDL cholesterol were all
determinedonRA500automatedanalyzer(TechniconIn-
strument Corporation, Tarry Town, NY) according to the
manufacturer’s recommendations. Serum glucose, creati-
nine, cholesterol, triglycerides, and HDL cholesterol were
all determined on an RA500 automated analyzer (Tech-
nicon Instrument Corporation, Tarry Town, NY) accord-
ing to the manufacturer’s recommendations. Serum low-
density lipoprotein (LDL) cholesterol was estimated us-
ing the Friedewald equation. Serum total insulin, vita-
min B12, and folate were all measured by radioisotopic
immunoassays, using the relevant commercial kits (for
insulin: Myria Technogenetics, Cassina de Pecchi, Italy,
intra- and interassay coeﬃcients of variation: 2.6% and
4.8% resp, sensitivity 2.1pmol/L; for vitamin B12,a n df o -
late: DPC, Los Angeles, Calif, intra- and interassay co-
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Table 1. Characteristics of the study participants. Data are n or means ± standard deviation.
Subjects (POC) Controls (PLC) p or P
n 72 42 —
Age (years)
Prepubertal children 8.9±0.39 .2±0.3 p = 0.78
BMI (kg/m2)3 0 .3±1.11 7 .4±0.5 p = 0.0001∗
Blood pressure (mmHg)
Systolic 124.8±12.8 122.1±10.4 p = 0.91
Diastolic 72.4±9.96 8 .8±8.6 p = 0.48
Total Homocysteine (µmol/L) 8.4±0.57 ±0.3 p = 0.02∗
Triglycerides (mmol/L) 1.6±0.81 .2±0.8 p = 0.02∗
Total cholesterol (mmol/L) 4.2±0.93 .9±0.9 p = 0.63
HDL cholesterol (mmol/L) 0.98±0.27 1.17±0.3 p = 0.003∗
LDL cholesterol (mmol/L) 2.33±0.94 2.11±0.7 p = 0.78
Glucose (mmol/L) 5.02±1.41 5.23±0.9 p = 0.65
Creatinine (µmol/L) 59.9±4.76 2 .1±4 p = 0.19
Total insulin (pmol/L) 141±24 102±19 p = 0.05∗
Vit B12 (pmol/L) 259±28 331±35 p = 0.09
Folate (nmol/L) 13.2±5.81 8 .9±8.3 p = 0.04∗
∗Statistically signiﬁcant possibility.
resp, sensitivity 0.2pmol/L, for folate: intra- and interas-
say coeﬃcients of variation 6.1% and 7.9% resp, sensitiv-
ity 0.7nmol/L).
StatisticalAnalysis
Variableswerecheckedfornormalityoftheirdistribu-
tion(Shapiro-Wilkstest;LillieforstestifN≥50).Datathat
werenotnormallydistributedwerelog10 transformed(to-
tal insulin, triglycerides, and glucose). However the arith-
metic mean concentrations are reported in the text and
tables. An unpaired t test was used to compare the avail-
able anthropometric and metabolic characteristics, except
tHcy, between POC and PLC. Multiple linear regression
was performed three times to evaluate the diﬀerence in
levels of CRP, SAA, and tHcy, each time, between POC
and PLC controlling in all cases for age and sex, as well
as log10 total insulin, vit B12, folate, total cholesterol, HDL
cholesterol, log10 triglycerides, and log10 glucose levels. To
evaluate the associations of BMI and SAA levels to CRP
levels as well as the association of BMI to SAA levels, mul-
tiple linear regression analysis was applied, adjusting for
age and sex, as well as log10 total insulin, vit B12,f o l a t e ,
total cholesterol, HDL cholesterol, log10 triglycerides and
log10 glucoselevels.Multiplelinearregressionwasalsoap-
plied to investigate the association of CRP and SAA levels
to tHcy levels, adjusting for age and sex, as well as log10
total insulin, vit B12, folate, total cholesterol, HDL choles-
terol, log10 triglycerides, and log10 glucose levels. The re-
sultsareexpressedasmean ±standarddeviation(SD).All
p (t test) or P (regression analysis) values are two-tailed
Table 2. CRP and SAA serum levels of the study participants.
Data are expressed as means ± standard deviation (median).
Parameter Subjects (POC) Controls (PLC)
CRP (mg/L) 3.6 ± 0.6 (3.2) 1.8 ± 0.7 (1.3)
SAA (ng/mL) 12.4 ± 2.6 (11.5) 14.3 ± 5.7 (15.6)
and P<. 05 is considered statistically signiﬁcant. The sta-
tistical package SPSS 8.0 (Statistical Package for the Social
Sciences, SPSS Inc, Chicago, Ill) was used.
RESULTS
POC and PLC presented no signiﬁcant diﬀerences
for all the rest available anthropometric and common
metabolic characteristics, except for BMI, tHcy, triglyc-
erides, and total insulin which were signiﬁcantly higher
i nP O Ct h a ni nP L C(p = 0.0001,p= 0.02,p= 0.02, and
p = 0.05, resp) and for HDL cholesterol and folate which
were signiﬁcantly lower in POC than in PLC (p = 0.003
and p = 0.04, resp) (Table 1). Circulating levels of CRP
(A) and SAA (B) for both POC and PLC are shown in
Table 2. The mean adjusted (for age and sex, as well as
log10 total insulin, vit B12, folate, total cholesterol, log10
triglycerides, and log10 glucose levels) diﬀerences in CRP
and SAA levels between POC and PLC were 3.12mg/L
(conﬁdence interval (CI): 0.19–6.05mg/L, P = 0.04) and
3.87ng/mL (CI: −16.66–24.39ng/mL, P = 0.71), respec-
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In the model of analysis used to evaluate the associ-
ation of BMI and SAA to CRP levels and the association
of BMI to SAA levels, OCA presented positive association
of age and log10 triglycerides, total cholesterol, glucose,
and log10 total insulin levels and negative association of
HDL-cholesterol to CRP (P=.02), but not to SAA levels.
Thus one mmol/L HDL cholesterol decrease was associ-
atedto14.2mg/L(Cl:2.9–22.2mg/L)increaseinCRPlev-
els. Furthermore, in this group, positive signiﬁcant asso-
ciation of BMI to CRP levels (P=.0001), but not to SAA
levels was noticed. Thus, one Kg/m2 increase in BMI was
associated with 0.44mg/L (Cl: 0.27–0.61mg/L) increase
in CRP levels. Furthermore, in POC, SAA levels were as-
sociated signiﬁcantly to CRP levels in a positive direction
(P=.02). Thus, one mg/L increase in CRP levels was asso-
ciated with a 4.25ng/mL (Cl: 1.5–5.8ng/mL) increase in
SAA levels.
In the model of analysis applied to investigate the as-
sociation of BMI, CRP, and SAA levels to tHcy levels, in
OCA, BMI as well as CRP and SAA levels were all not as-
sociated signiﬁcantly with tHcy levels.
DISCUSSION
To our knowledge, this is the ﬁrst study that extrapo-
lates in POC the proﬁle of the chronic low-grade systemic
inﬂammation with regard to SAA and its possible interre-
lation to circulating CRP. Furthermore, this study inves-
tigates, for the ﬁrst time in POC, the association among
the markers of chronic low-grade systemic inﬂammation
of this speciﬁc proﬁle and plasma levels of tHcy.
The data from this study demonstrate that (a) CRP
levels are higher in POC than in PLC, (b) SAA levels do
not diﬀer between POC and PLC, (c) a positive associ-
ation of BMI to CRP levels, not to SAA levels, exists in
POC, (d) a negative association of HDL cholesterol to
CRP levels, not to SAA levels, also exists in POC, and (e)
the positively interrelated CRP and SAA levels fail to asso-
ciate with tHcy in POC.
The participants of the present study were all under
the age of 10 years to avoid any signiﬁcant interference
of puberty-related insulin resistance as well as circulat-
ing insulin and glucose levels enhancement, although it
has recently been postulated that hyperinsulinemia and
insulin resistance are already present in POC [21]. In-
deed, in this study POC presented higher insulin levels
than those of PLC. Accordingly, adjustment for insulin
levels of all the results of the study was performed. How-
ever, glucose homeostasis was maintained in POC, since
no signiﬁcant variations in circulating glucose levels were
observed between POC and PLC. This probably reﬂects
a potentially reversible hyperinsulinemia indicative of a
stagebeforetheonsetofpuberty-relatedinsulinresistance
in POC.
Circulating CRP is not only a widely accepted marker
of chronic low-grade systemic inﬂammation, but more-
over it is a direct promoter of vascular disease. A variety
of mechanisms by which CRP might promote vascular
disease (such as its frequent detection in atherosclerotic
plaques, its ability to stimulate tissue factor production
by macrophages, and its enhancement of complement ac-
tivation after binding partly degraded, nonoxidized low
density lipoprotein cholesterol) have been proposed, but
none is proved. In this study, higher CRP levels were no-
ticed in POC, compared to those noticed in PLC. More-
over, a strong positive association of body mass index
(BMI),generallyacceptednowtobeusedtodeﬁneobesity
in children and adolescents clinically [1], to CRP levels
was noticed only in POC. These results conﬁrm previous
relevant ﬁndings in children [4] and extend previous re-
search in adults [22] to children. In addition, a negative
association of decreased HDL cholesterol levels to CRP
was observed. This proatherogenic, noncausative associ-
ation extends, for the ﬁrst time, previous results in adults
[23, 24] to children. Accordingly, excess body weight es-
timated by BMI is evidently associated with a state of
chronic low-grade systemic inﬂammation in POC.
SAA is a not-often-used marker of chronic low-grade
systemic inﬂammation. However, several ﬁndings em-
phasize the importance of SAA in various physiological
and pathological processes, including inﬂammation and
atherosclerosis. Although the precise role of SAA has not
been deﬁned, many potential clinically important athero-
genic functions have been proposed [15]. These include
involvement in lipid metabolism/transport, amyloid A
amyloidosis, induction of extracellular-matrix-degrading
enzymes, and chemotactic recruitment of inﬂammatory
cells. On the contrary, other data coupled with obser-
vations in which SAA was found to induce endothelial
prostaglandin I2 (PGI2) formation and to inhibit over-
production of PGI2 by TNF and lipopolysacharides (LPS)
as well as platelet aggregation may suggest that SAA con-
tributes to the protective eﬀect of HDL cholestrol against
atherosclerosis.
Several studies reported elevation of SAA levels in
unstable coronary syndromes [11, 15] and spontaneous
or transplant-associated coronary artery disease [11]. Ac-
companied by circulating CRP elevation, circulating SAA
elevation has been reported in type-2 diabetic patients
[25], in patients with coronary heart disease [26], and
in patients at risk for future coronary occlusion [13].
However, some studies have suggested that SAA levels
are not necessarily accompanied by CRP levels in any
changes. Accordingly, circulating SAA but not CRP ele-
vation was observed in patients with mild to moderate
essential hypertension [14]. In addition, the extent and
severity of atherosclerosis of left coronary arteries, eval-
uated by Gensini Score, correlated with the percentage
changes in SAA across coronary circulation but not with
changes in CRP [5].Ontheotherhand,SAAlevelsarenot
associated with peripheral artery disease, in contrary to
CRP levels which are associated with lower summary per-
formancescoreamongpatientswithperipheralarterydis-
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POC and PLC. Combined with the increased CRP levels,
this result may indicate that control mechanisms sepa-
rately permit circulating CRP elevation but not SAA el-
evation in POC. This is likely to be of relevance to the
causation of future atherosclerosis.
An important observation of the present study is
that decreased HDL cholesterol are not associated to un-
altered SAA levels in POC. It has been previously re-
ported [28] that raised SAA lowers HDL cholesterol lev-
els causatively, through association with lipoproteins of
the high-density range, which alters HDL cholestrol ef-
ﬂux, to be the principal role of SAA. Thus, the unre-
lated to decreased HDL cholesterol levels, unaltered SAA
levels may limit the proatherogenic potential of the re-
lated to decreased HDL cholestrol, raised CRP levels. In
addition, no association of BMI to SAA levels was no-
ticed in POC. The lack of this association is a diﬀeren-
tial ﬁnding for POC, since association of BMI to SAA
levels has been described in type-2 diabetic patients [25]
and even more in healthy adults without history of coro-
nary artery disease [29]a sw e l la si nh e a l t h yw o m e n
[22]. As circulating levels of both CRP and SAA have
been separately associated with increased risk of coro-
nary heart disease, the close interrelation between CRP
and SAA levels observed in POC increases the likelihood
that there is some underlying process related to inﬂam-
mation which is relevant to the causation of the disease
[13].
These results revealed, for the ﬁrst time, a diﬀerential,
in comparison to other subpopulations studied [5, 13, 14,
15], proﬁle of chronic low-grade systemic inﬂammation
in that, although close interrelated, only CRP levels, neg-
atively related to decreased HDL cholesterol, not SAA lev-
els, unrelated to decreased HDL cholesterol, are elevated
in POC.
Conﬁrming several previous ﬁndings in both adults
and children [19, 21], we recently demonstrated [20]a n
unrelated to BMI, mild elevation of tHcy levels in POC as
compared to tHcy levels measured in PLC, which might
be regarded as an indicator of the global cardiovascular
risk. The present study failed to observe an association
of CRP or SAA levels to tHcy levels in POC. This ﬁnd-
ing extends for the ﬁrst time previous ﬁnding in adults
to children and may imply that prepubertal childhood
obesity-speciﬁcchroniclow-gradesystemicinﬂammation
doesnotcontributetohomocysteinemia-inducedpromo-
tion of atherosclerosis.
A shortcoming of this study might be that vitamin B6,
insulin resistance, total antioxidant status, as well as lep-
tin levels were not measured. Some of them such as vita-
min B6 and insulin resistance have been reported as de-
terminants for circulating markers of chronic low-grade
inﬂammation, including CRP, but they all represent only
some of the determinants for plasma levels of tHcy [30].
In most cases, an abnormal CRP or tHcy status is not
caused by a single factor alone but often is the result of
combined eﬀects.However, it was not only out of the pur-
poseofthisstudy,butalsoitwasimpossibletoevaluateall
the known determinants of CRP and SAA or tHcy levels
in the limits of a single study. Moreover, the subjects of
this study, except for being obese, were all biochemically
and clinically, apparently healthy.
In conclusion, this study provides evidence that in
prepubertal childhood obesity a unique proﬁle of chronic
low-grade systemic inﬂammation in that, although they
are closely interrelated, only CRP, negatively related to de-
creased HDL cholesterol, not SAA levels, unrelated to de-
creased HDL cholesterol, are elevated in POC, is evoked.
This POC-speciﬁc chronic low-grade systemic inﬂamma-
tion cannot explain the link between homocysteinemia,
observed in childhood obesity, and future atherosclerosis.
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